Transgene Biotek Limited (BOM:526139)

Transgene Biotek Revenue

In the fiscal year ending March 31, 2026, Transgene Biotek had annual revenue of 3.61M INR with 38.51% growth. Transgene Biotek had revenue of 2.04M in the quarter ending March 31, 2026, with 167.06% growth.

• Revenue: 3.61M
• Revenue Growth: +38.51%
• P/S Ratio: 65.26
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 235.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.61M	1.00M	38.51%
Mar 31, 2025	2.61M	258.00K	10.98%
Mar 31, 2024	2.35M	1.80M	326.32%
Mar 31, 2023	551.00K	-315.95K	-36.44%
Mar 31, 2022	866.95K	-828.55K	-48.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error